- Home
- QNCX vs SRZN Comparison
QNCX vs SRZN Comparison
Compare QNCX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SRZN
- Stock Information
- Founded
- QNCX 2012
- SRZN 2015
- Country
- QNCX United States
- SRZN United States
- Employees
- QNCX N/A
- SRZN N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- QNCX Health Care
- SRZN Health Care
- Exchange
- QNCX Nasdaq
- SRZN Nasdaq
- Market Cap
- QNCX 34.4M
- SRZN 38.1M
- IPO Year
- QNCX 2019
- SRZN N/A
- Fundamental
- Price
- QNCX $2.08
- SRZN $9.30
- Analyst Decision
- QNCX Strong Buy
- SRZN
- Analyst Count
- QNCX 3
- SRZN 0
- Target Price
- QNCX $9.67
- SRZN N/A
- AVG Volume (30 Days)
- QNCX 1.1M
- SRZN 33.9K
- Earning Date
- QNCX 11-13-2024
- SRZN 11-06-2024
- Dividend Yield
- QNCX N/A
- SRZN N/A
- EPS Growth
- QNCX N/A
- SRZN N/A
- EPS
- QNCX N/A
- SRZN N/A
- Revenue
- QNCX N/A
- SRZN $10,000,000.00
- Revenue This Year
- QNCX N/A
- SRZN N/A
- Revenue Next Year
- QNCX N/A
- SRZN N/A
- P/E Ratio
- QNCX N/A
- SRZN N/A
- Revenue Growth
- QNCX N/A
- SRZN N/A
- 52 Week Low
- QNCX $0.51
- SRZN $6.00
- 52 Week High
- QNCX $2.14
- SRZN $16.19
- Technical
- Relative Strength Index (RSI)
- QNCX 73.91
- SRZN 45.92
- Support Level
- QNCX $1.56
- SRZN $8.10
- Resistance Level
- QNCX $2.14
- SRZN $10.76
- Average True Range (ATR)
- QNCX 0.21
- SRZN 1.25
- MACD
- QNCX 0.02
- SRZN -0.16
- Stochastic Oscillator
- QNCX 91.89
- SRZN 22.90
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).